Previous close | 0.2900 |
Open | 0.2900 |
Bid | 0.2900 |
Ask | 0.3400 |
Strike | 85.00 |
Expiry date | 2024-08-16 |
Day's range | 0.2900 - 0.2900 |
Contract range | N/A |
Volume | |
Open interest | 87 |
The European Commission approves AstraZeneca's (AZN) Tagrisso in combination with chemotherapy for first-line treatment of advanced EGFR-mutated NSCLC based on data from the phase III FLAURA2 study.
Eli Lilly (LLY) wins FDA approval for its Alzheimer's disease drug, Kisunla. (donanemab). Sanofi (SNY) and Regeneron's Dupixent gets approval for COPD in Europe.
Generally speaking the aim of active stock picking is to find companies that provide returns that are superior to the...